English | Español
Patient Daily | Mar 16, 2026

FDA warns Novo Nordisk over unreported Ozempic safety events, including deaths
Patient Daily | Mar 16, 2026

Pharma faces fierce M&A competition as late-stage assets become scarce
Patient Daily | Mar 16, 2026

Study suggests matcha may reduce sneezing in people with nasal allergies
Patient Daily | Mar 16, 2026

Study links aging gut to cognitive decline in mice, suggests possible interventions
Patient Daily | Mar 16, 2026

Researchers identify mechanism explaining chemical disruption of sex hormones
Patient Daily | Mar 16, 2026

Study links dual-positive hybrid cells to shorter survival in advanced breast cancer
Patient Daily | Mar 16, 2026

Long-term study reveals lifelong challenges for children with single-ventricle heart disease
Patient Daily | Mar 16, 2026

Vanderbilt Health begins clinical trial for new implant to treat male urinary incontinence

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug